Identification of a novel secretory leukocyte protease inhibitor-binding protein involved in membrane phospholipid movement

FEBS Lett. 2000 Jun 23;475(3):232-6. doi: 10.1016/s0014-5793(00)01700-2.

Abstract

Previous studies have suggested that human salivary secretory leukocyte protease inhibitor (SLPI) inhibits HIV-1 by binding to a host cell surface protein of unknown identity. Using the yeast two-hybrid assay, we identified a gene sequence encoding a novel SLPI-binding protein (SLPI-BP). The 1.5-kb cDNA encodes a 318-amino acid protein with a predicted transmembrane segment near the C-terminus. Sequence analysis revealed that SLPI-BP is the human scramblase protein that is involved in the movement of membrane phospholipids. Co-expression of SLPI and SLPI-BP followed by an S-protein pulldown assay confirmed the specific interaction between these two proteins. Our data represent the first report for the identity of SLPI-BP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • HIV-1 / metabolism
  • Humans
  • Membrane Fluidity
  • Membrane Lipids / metabolism*
  • Molecular Sequence Data
  • Phospholipids / metabolism
  • Protein Binding
  • Proteinase Inhibitory Proteins, Secretory
  • Proteins / metabolism*
  • Salivary Proteins and Peptides / genetics
  • Salivary Proteins and Peptides / metabolism*
  • Secretory Leukocyte Peptidase Inhibitor

Substances

  • Membrane Lipids
  • Phospholipids
  • Proteinase Inhibitory Proteins, Secretory
  • Proteins
  • SLPI protein, human
  • Salivary Proteins and Peptides
  • Secretory Leukocyte Peptidase Inhibitor